Clinical Trial Update: HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating hepatic arterial infusion chemotherapy combined with immune therapy for advanced, non-resectable intrahepatic cholangioca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: ICC, Advanced Cancer | Phase 2 | Status: RECRUITING